Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Prostate Biopsies - A Retrospective Review From the University Malaya Medical Center

Dublin, N., (2003) Prostate Biopsies - A Retrospective Review From the University Malaya Medical Center. Medical Journal of Malaysia, 58 (5). pp. 673-677. ISSN 0300-5283

Full text not available from this repository.

Affiliations

University of Malaya Medical Centre. Dept. of Surgery. Urology Unit.

Abstract

Prostate cancer is not common in south-east asia and in particular there are only scarce reports on the characteristics of Malaysian men with prostate cancer. A retrospective study where all prostate specimens sent to the pathology department during the period 1st January 1996 to 30th June 1998 were reviewed. A total of 131 prostate specimens were reviewed and these consisted of prostatectomy specimens, transurethral resection specimens and trucut biopsy specimens. Only 114 patients’ case notes were evaluated. Data reviewed were age, race, presenting symptoms, clinical findings and prostate-specific antigen (PSA) level. Overall incidence of carcinoma of the prostate was 19.0%. The incidence of carcinoma of the prostate with serum prostate-specific antigen (PSA) of 4.1 to 20.0 ng/ml was only 10% and 60.5% of patients had evidence of subclinical histological prostatitis. The mean age of men with carcinoma of the prostate was 71.3 years and there was no differences in the incidence of carcinoma of the prostate among the 3 major ethnic groups (Malays, Chinese and Indian). About three-quarter of the patients with carcinoma of the prostate presented with lower urinary tract symptoms, a third had haematuria and about a tenth of patients presented with urinary retention. The majority of patients presented with metastatic disease (66.7%) with a mean PSA of 1476.8 ng/ml. A significant proportion of men with prostatic diseases attending the University of Malaya Medical Center had prostate cancer (19.0%). A small proportion of men with serum PSA in the range of 4.1 to 20.0 ng/ml had prostate cancer and this is thought to be due to the background histological prostatitis. The majority of patients presented late.

Item Type:Journal
Keywords:Prostate cancer, Histological prostatitis, Malaysia
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6947

1. Cancer Facts & Figures - 1997. Page 9. American Cancer Society. http://www.cancer.org/downloads/STT/F&F97.pdf

2. Keetch DW. Epidemiology and etiology, In: Hamdy FC et al (eds). Management of Urologic Malignancies. Churchill Livingstone, 2002: 111-16.

3. Yu HJ, Chie WC, Hsieh CH et al. Clinical efficiency of prostate-specific antigen testing in patients with prostate disease. J Formos Med Assoc 1996; 95: 782-8.

4. Yu HJ, Lai MK. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Urology 1998; 51: 125-30.

5. Lim TC. Prostate Cancer Detection in patients with raised prostate-specific antigen in a clinical urological practice: A retrospective study. Proceedings of the 8th Malaysian Urological Conference 1998; 74.

6. http://sarawak.health.gov.my/cancerre/cancer3.htm

7. Png JC, Akhtar KJ, Tung KH. Role of PSA testing in multiphasic health screening. Singapore Med J 1998; 39: 193-5.

8. Teh GC. Prostate cancer: The Kuala Lumpur Hospital's Experience. Proceedings of the 8th Malaysian Urological Association 1998; 78.

9. Koh JS, Cheng CW, Foo KT. Spectrum of prostate cancer in the Singapore General Hospital (1980 to 1985). Ann Acad Med Singapore 2001; 30: 513-5.

10. Lim TC. Prostate cancer detection in screening volunteers by digital rectal examination, transrectal ultrasonography (TRUS), Prostate-specific antigen (PSA) and PSA Density (PSAD): A prospective study. Proceedings of the 8th Malaysian Urological Conference 1998: 76.

11. Hasui Y, Marutsuka K, Asada Y et al. Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25: 91-6.

12. Nadler RB, Humphrey PA, Smith DS et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154: 407-13.

13. Hoekx L, Jeuris W, Van Marck E, Wyndaele JJ. Elevated serum prostate-specific antigen (PSA) related to asymptomatic prostate inflammation. Acta Urol Belg 1998; 66: 1-2.

Repository Staff Only: item control page